XFORNasdaqBiological Products, (No Diagnostic Substances)

X4 Pharmaceuticals, Inc (XFOR) earnings date, market-implied expected move, and options open interest by expiry

3.22

+0.05 · +1.60%

Regular session15:50 ET

Open3.27Volume630,191Mkt cap$314.3MEPS-0.71

Day3.14 – 3.2762%52-wk2.43 – 4.8333%

XFOR

X4 Pharmaceuticals, Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Mar 19

before open · in 135 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

—

Supply chain

13F top-10 QoQ

+6.42%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

89 managers

Top fund weight

0.01%

XFOR weight · IWM

N-PORTJun 30 '26

3 funds

X4 Pharmaceuticals (XFOR) is expected to report on Mar 19 before open (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 2 expiries · Nov 3 close

0.00OI · 2 expiries · Nov 3 closeP/C open interest · Mar 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

0—Dec 1844d0.006,145−4%0.00

report · Mar 19 · before open · est.

0—Mar 19135d4,374+51%

ExpiryPutsCallsP/C

Dec 1844d0—6,145−4%0.00

report · Mar 19 · before open · est.

Mar 19135d0—4,374+51%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−183.48%as filednet margin · revenue +225.18% QoQ · +346.33% YoY

Revenue$9M+225.18%

Gross profit$7M81.64%+240.71%

Operating income−$16M−186.13%+19.28%

Pre-tax income−$16M+20.19%

Net income−$16M−183.48%+20.18%

Cost of revenue$2M+170.40%

Operating expenses$24M+5.19%

Tax$2,000—

Other income$236,000+263.08%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

FOMC ×1.22· ±5.8% vs ±4.7% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±5.8%12 of 24×1.22

PCEpersonal income & outlays±3.6%8 of 19×0.75

GDPgross domestic product±3.4%7 of 19×0.71

NFPjobs report±3.2%4 of 10×0.67

PPIproducer prices±3.0%4 of 10×0.63

CPIconsumer prices±2.5%5 of 10×0.52

CPROFcorporate profits±2.4%7 of 12×0.51

Bar = avg |move| to ±6% · tick = ±4.7% avg day · ×base = |move| ÷ ±4.7% · min 6 releases

Earnings history

EPS -0.13 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.13	—
Q1 FY26	—	-0.16	—
Q3 FY25	—	-0.69	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod